National Institute of Allergy and Infectious Diseases; Notice of Meetings, 58168-58169 [2024-15711]
Download as PDF
<![CDATA[
58168
Federal Register / Vol. 89, No. 137 / Wednesday, July 17, 2024 / Notices
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The meeting
can be accessed from the NIH Videocast
at the following link: https://
videocast.nih.gov/.
Name of Committee: AIDS Research
Advisory Committee, NIAID.
Date: September 9, 2024.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: Report of Division Director
and Division Staff.
Place: National Institute of Allergy
and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane,
Grand Hall, Rockville, MD 20892
(Hybrid Meeting).
Contact Person: Pamela Gilden,
Branch Chief, Science Planning and
Operations Branch, Division of AIDS,
National Institute of Allergy and
Infectious Diseases, National Institutes
of Health, 5601 Fishers Lane, MSC 9831,
Rockville, MD 20852–9831, 301–594–
9954, pamela.gilden@nih.gov.
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/
about-nih/visitor-information/campusaccess-security for entrance into oncampus and off-campus facilities. All
visitor vehicles, including taxicabs,
hotel, and airport shuttles will be
inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal
facility will be asked to show one form
of identification (for example, a
government-issued photo ID, driver’s
license, or passport) and to state the
purpose of their visit.
ddrumheller on DSK120RN23PROD with NOTICES1
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: July 12, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–15710 Filed 7–16–24; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
19:21 Jul 16, 2024
Jkt 262001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of
Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of
meetings of the National Advisory
Allergy and Infectious Diseases Council.
The meetings will be open to the public
as indicated below, with attendance
limited to space available. Individuals
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
Contact Person listed below in advance
of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National
Advisory Allergy and Infectious
Diseases Council.
Date: September 9, 2024.
Open: 10:30 a.m. to 11:30 a.m.
Agenda: Report of Institute Director.
Place: National Institute of Allergy
and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane,
Grand Hall, Rockville, MD 20892
(Hybrid Meeting).
Closed: 11:45 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy
and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane,
Grand Hall, Rockville, MD 20892
(Hybrid Meeting).
Contact Person: Kelly Y. Poe, Ph.D.,
Director, Division of Extramural
Activities, National Institute of Allergy
and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane,
Room 3F40B, Bethesda, MD 20892–
9834, (240) 669–5036, poeky@
mail.nih.gov.
Name of Committee: National
Advisory Allergy and Infectious
Diseases Council Microbiology and
Infectious Diseases Subcommittee.
Date: September 9, 2024.
Closed: 8:30 a.m. to 10:15 a.m.
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy
and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane,
Garden Room 2, Rockville, MD 20892
(Hybrid Meeting).
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of the Division
Director and Division Staff.
Place: National Institute of Allergy
and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane,
Garden Room 2, Rockville, MD 20892
(Hybrid Meeting).
Contact Person: Kelly Y. Poe, Ph.D.,
Director, Division of Extramural
Activities, National Institute of Allergy
and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane,
Room 3F40B, Bethesda, MD 20892–
9834, (240) 669–5036, poeky@
mail.nih.gov.
Name of Committee: National
Advisory Allergy and Infectious
Diseases Council Immunology and
Transplantation Subcommittee.
Date: September 9, 2024.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy
and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane,
Garden Room 1, Rockville, MD 20892
(Hybrid Meeting).
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of the Division
Director and Division Staff.
Place: National Institute of Allergy
and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane,
Garden Room 1, Rockville, MD 20892
(Hybrid Meeting).
Contact Person: Kelly Y. Poe, Ph.D.,
Director, Division of Extramural
Activities, National Institutes of Health,
NIAID, National Institutes of Health,
5601 Fishers Lane, Room 3F40B,
Bethesda, MD 20892–9834, (240) 669–
5036, poeky@mail.nih.gov.
Name of Committee: National
Advisory Allergy and Infectious
Diseases Council Acquired
Immunodeficiency Syndrome
Subcommittee.
Date: September 9, 2024.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy
and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane,
Grand Hall, Rockville, MD 20892
(Hybrid Meeting).
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of the Division
Director and Division Staff.
E:\FR\FM\17JYN1.SGM
17JYN1
Federal Register / Vol. 89, No. 137 / Wednesday, July 17, 2024 / Notices
Place: National Institute of Allergy
and Infectious Diseases, National
Institutes of Health, Conference Room:
Grand Hall, 5601 Fishers Lane,
Rockville, MD 20892 (Hybrid Meeting).
Contact Person: Kelly Y. Poe, Ph.D.,
Director, Division of Extramural
Activities, National Institute of Allergy
and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane,
Room 3F40B, Bethesda, MD 20892–
9834, (240) 669–5036, poeky@
mail.nih.gov.
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/
about-nih/visitor-information/campusaccess-security for entrance into oncampus and off-campus facilities. All
visitor vehicles, including taxicabs,
hotel, and airport shuttles will be
inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal
facility will be asked to show one form
of identification (for example, a
government-issued photo ID, driver’s
license, or passport) and to state the
purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.niaid.nih.gov/about/advisorycouncil, where an agenda and any
additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: July 12, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–15711 Filed 7–16–24; 8:45 am]
ddrumheller on DSK120RN23PROD with NOTICES1
BILLING CODE 4140–01–P
DEPARTMENT OF THE INTERIOR
Fish and Wildlife Service
[FWS–R2–ES–2024–N030;
FXES11130200000–245–FF02ENEH00]
Endangered Wildlife; Recovery Permit
Applications
Fish and Wildlife Service,
Interior.
ACTION: Notice of receipt of permit
applications; request for comments.
AGENCY:
We, the U.S. Fish and
Wildlife Service, invite the public to
comment on the following applications
for a permit to conduct activities
intended to recover and enhance
endangered species survival. With some
exceptions, the Endangered Species Act
(ESA) prohibits certain activities that
may impact endangered species, unless
a Federal permit allows such activity.
The ESA also requires that we invite
public comment before issuing these
permits.
SUMMARY:
To ensure consideration, please
submit your written comments by
August 16, 2024.
ADDRESSES:
Document availability: Request
documents from the contact in the FOR
FURTHER INFORMATION CONTACT section.
Comment submission: Submit
comments by email to fw2_te_permits@
fws.gov. Please specify the permit
application you are interested in by
number (e.g., Permit Record No.
PER1234567).
DATES:
FOR FURTHER INFORMATION CONTACT:
Marty Tuegel, Supervisor,
Environmental Review Division, by
phone at 505–248–6651, or via email at
marty_tuegel@fws.gov. Individuals in
the United States who are deaf,
deafblind, hard of hearing, or have a
speech disability may dial 711 (TTY,
TDD, or TeleBraille) to access
telecommunications relay services.
Individuals outside the United States
should use the relay services offered
within their country to make
international calls to the point-ofcontact in the United States.
SUPPLEMENTARY INFORMATION:
Background
With some exceptions, the
Endangered Species Act of 1973, as
VerDate Sep<11>2014
19:21 Jul 16, 2024
Jkt 262001
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
58169
amended (ESA; 16 U.S.C. 1531 et seq.),
prohibits activities that constitute take
of listed species unless a Federal permit
is issued that allows such activity. The
ESA’s definition of ‘‘take’’ includes
hunting, shooting, harming, wounding,
or killing, and also such activities as
pursuing, harassing, trapping, capturing,
or collecting.
The ESA and our implementing
regulations in the Code of Federal
Regulations (CFR) at title 50, part 17,
provide for issuing such permits and
require that we invite public comment
before issuing permits for activities
involving listed species.
A recovery permit we issue under the
ESA, section 10(a)(1)(A), authorizes the
permittee to conduct activities with
endangered or threatened species for
scientific purposes that promote
recovery or enhance the species’
propagation or survival. These activities
often include such prohibited actions as
capture and collection. Our regulations
implementing section 10(a)(1)(A) for
these permits are found at 50 CFR 17.22
for endangered wildlife species, 50 CFR
17.32 for threatened wildlife species, 50
CFR 17.62 for endangered plant species,
and 50 CFR 17.72 for threatened plant
species.
Permit Applications Available for
Review and Comment
Documents and other information
submitted with these applications are
available for review by any party who
submits a request as specified in
ADDRESSES. Our release of documents is
subject to Privacy Act (5 U.S.C. 552a)
and Freedom of Information Act (5
U.S.C. 552) requirements.
Proposed activities in the following
permit requests are for the recovery and
enhancement of propagation or survival
of the species in the wild. We invite
local, State, Tribal, and Federal agencies
and the public to submit written data,
views, or arguments with respect to
these applications. The comments and
recommendations that will be most
useful and likely to influence agency
decisions are those supported by
quantitative information or studies.
Please refer to the permit record number
when submitting comments.
E:\FR\FM\17JYN1.SGM
17JYN1
]]>Agencies
[Federal Register Volume 89, Number 137 (Wednesday, July 17, 2024)]
[Notices]
[Pages 58168-58169]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-15711]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of meetings of the National Advisory
Allergy and Infectious Diseases Council. The meetings will be open to
the public as indicated below, with attendance limited to space
available. Individuals who plan to attend and need special assistance,
such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Allergy and Infectious
Diseases Council.
Date: September 9, 2024.
Open: 10:30 a.m. to 11:30 a.m.
Agenda: Report of Institute Director.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Grand Hall,
Rockville, MD 20892 (Hybrid Meeting).
Closed: 11:45 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Grand Hall,
Rockville, MD 20892 (Hybrid Meeting).
Contact Person: Kelly Y. Poe, Ph.D., Director, Division of
Extramural Activities, National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3F40B,
Bethesda, MD 20892-9834, (240) 669-5036, [email protected].
Name of Committee: National Advisory Allergy and Infectious
Diseases Council Microbiology and Infectious Diseases Subcommittee.
Date: September 9, 2024.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Garden Room 2,
Rockville, MD 20892 (Hybrid Meeting).
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of the Division Director and Division Staff.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Garden Room 2,
Rockville, MD 20892 (Hybrid Meeting).
Contact Person: Kelly Y. Poe, Ph.D., Director, Division of
Extramural Activities, National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3F40B,
Bethesda, MD 20892-9834, (240) 669-5036, [email protected].
Name of Committee: National Advisory Allergy and Infectious
Diseases Council Immunology and Transplantation Subcommittee.
Date: September 9, 2024.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Garden Room 1,
Rockville, MD 20892 (Hybrid Meeting).
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of the Division Director and Division Staff.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Garden Room 1,
Rockville, MD 20892 (Hybrid Meeting).
Contact Person: Kelly Y. Poe, Ph.D., Director, Division of
Extramural Activities, National Institutes of Health, NIAID, National
Institutes of Health, 5601 Fishers Lane, Room 3F40B, Bethesda, MD
20892-9834, (240) 669-5036, [email protected].
Name of Committee: National Advisory Allergy and Infectious
Diseases Council Acquired Immunodeficiency Syndrome Subcommittee.
Date: September 9, 2024.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Grand Hall,
Rockville, MD 20892 (Hybrid Meeting).
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of the Division Director and Division Staff.
[[Page 58169]]
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, Conference Room: Grand Hall, 5601
Fishers Lane, Rockville, MD 20892 (Hybrid Meeting).
Contact Person: Kelly Y. Poe, Ph.D., Director, Division of
Extramural Activities, National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3F40B,
Bethesda, MD 20892-9834, (240) 669-5036, [email protected].
Any interested person may file written comments with the committee
by forwarding the statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person.
In the interest of security, NIH has procedures at https://www.nih.gov/about-nih/visitor-information/campus-access-security for
entrance into on-campus and off-campus facilities. All visitor
vehicles, including taxicabs, hotel, and airport shuttles will be
inspected before being allowed on campus. Visitors attending a meeting
on campus or at an off-campus federal facility will be asked to show
one form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their visit.
Information is also available on the Institute's/Center's home
page: https://www.niaid.nih.gov/about/advisory-council, where an agenda
and any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: July 12, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-15711 Filed 7-16-24; 8:45 am]
BILLING CODE 4140-01-P
